A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Clinical trial NCT07105215 · RECRUITING
Trial details
- NCT number
- NCT07105215
- Sponsor
- RemeGen Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-11
- Primary completion
- 2027-12-31
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.